Corcept Therapeutics

NASDAQ: CORT · Real-Time Price · USD
71.72
-0.28 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
71.75
0.03%
After-hours: Aug 15, 2025, 04:54 PM EDT

Corcept Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
133.3M 133.27M 140.24M 141.2M 125.37M 117.78M 106.14M 91.39M 94.62M 94.5M 101.42M 116.87M 112.73M 111.84M 112.51M 106.45M 97.61M 99.41M
Depreciation & Amortization
1.89M 1.68M 1.34M 1.51M 1.18M 1.74M 2.36M 2.48M 3.06M 2.91M 2.97M 3.02M 3.04M 3.13M 3.07M 2.83M 2.63M 2.38M
Stock-Based Compensation
73.75M 69.94M 61.35M 57.62M 54.4M 51.05M 48.94M 46.4M 44.07M 42.82M 42.44M 42.73M 43.13M 43.59M 42.93M 40.55M 38.3M 35.72M
Other Working Capital
20.54M 15.23M 46.09M 3.42M -15.45M 6.08M 4.82M 39.94M 23.16M -2.09M 3.49M -2.36M 2.1M 14.79M 1.52M 554K -4.26M -2.62M
Other Non-Cash Items
-21.64M -28.29M 16.93M 15.57M 15.68M 13.59M -9.13M -6.67M -3.67M -1.23M 1.38M 3.41M 4.49M 5M 5.09M 4.7M 3.85M 2.82M
Deferred Income Tax
-50.53M -46.73M -40.19M -40.01M -33.66M -29.93M -29.49M -30.29M -30.3M -30.7M -33.91M -27.14M -14.16M -229K 4.35M 4.36M 2.01M 3.63M
Change in Working Capital
45.44M 52.71M 45.3M -4.35M -12.34M -5.62M 8.22M 51.24M 27.5M 2.73M 6.02M -2.53M 2.18M 14.38M -57K -5.36M -9.11M 156K
Operating Cash Flow
182.2M 179.44M 198.07M 144.65M 123.73M 124.84M 127.04M 154.54M 135.28M 111.03M 120.32M 136.36M 151.42M 177.72M 167.89M 153.54M 135.28M 144.12M
Capital Expenditures
-1.92M -2.28M -2.17M -2.05M -453K -139K -139K -170K -484K -401K -413K -447K -255K -355K -469K -835K -1.39M -1.32M
Cash Acquisitions
n/a n/a n/a n/a 109.53M 133.53M 133.53M 150.74M 45.64M 63.43M 63.43M 46.22M 41.78M n/a n/a n/a n/a n/a
Purchase of Investments
-506.13M -625.58M -588.31M -473.64M -460.54M -406.62M -328.75M -395.49M -264.31M -262.45M -355.07M -258.42M -269.11M -278.03M -312.81M -409.82M -424.07M -499.03M
Sales Maturities Of Investments
466.6M 456.09M 412.88M 379.55M 299.31M 281.18M 419.79M 452.23M 426.14M 406.5M 241.15M 302.25M 291.74M 367.3M 449.4M 417.54M 393.87M 358.07M
Other Investing Acitivies
n/a -59.78M -68.79M -51.69M -161.23M -125.44M 91.05M 56.74M 161.83M 144.04M -113.91M 43.83M 22.63M 89.27M 136.59M 7.71M -30.2M -140.96M
Investing Cash Flow
-41.44M -171.76M -177.6M -96.15M -161.68M -125.58M 90.91M 56.57M 161.35M 143.64M -114.33M 43.38M 22.37M 88.91M 136.13M 6.88M -31.59M -142.28M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-142.16M -42.62M -15.66M -161.09M -154.44M -296.39M -297.14M -152.56M -163.13M -21M -21.66M -228.32M -238.47M -264.33M -295.99M -98.16M -72.41M -43.3M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-65.38M -67.37M -28.11M -22.78M -543K -458K 266K -1.35M -825K -1.76M -2.44M -4.11M -3.65M 2.25M -13.69M -12.15M -8.42M -4.75M
Financial Cash Flow
-168.39M -67.61M -28.35M -23.02M -5.84M -149.45M -148.72M -149.55M -159.59M -16.6M -17.28M -224.19M -233.87M -257.15M -302.59M -96.28M -66.77M -33.94M
Net Cash Flow
-25.84M -59.93M -7.89M 25.49M -43.79M -150.19M 69.22M 61.56M 137.03M 238.08M -11.29M -44.45M -60.08M 9.48M 1.43M 64.13M 36.91M -32.1M
Free Cash Flow
180.28M 177.16M 195.9M 142.6M 123.28M 124.7M 126.9M 154.37M 134.79M 110.63M 119.91M 135.91M 151.16M 177.36M 167.42M 152.7M 133.88M 142.8M